<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhang Y</submitter><funding>Mike Slive Foundation for Prostate Cancer Research</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Cancer Institute</funding><funding>U.S. Department of Defense</funding><funding>NCI NIH HHS</funding><pagination>3186-3196</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9177620</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>41(23)</volume><pubmed_abstract>For human prostate cancer, the chromosome 8p21 locus, which contains NKX3.1 and the microRNA (miR)-3622 family (miR-3622a/b), is a frequently deleted region. Thus, miR-3622 is proposed as a suppressor for prostate cancer, but its role remains debatable. In the present study, we found that expression of miR-3622a was lower, whereas expression of miR-3622b-3p was higher in human prostate cancer tissues than in normal prostate tissues. miR-3622a-3p inhibited cell migration and invasion of human prostate cancer cells, whereas miR-3622b-3p facilitated cell proliferation, migration, and invasion. To address the opposing roles of miR-3622 family members in various human prostate cancer cell lines, we knocked out (KO) endogenous miR-3622, including both miR-3622a/b. Our results showed that miR-362</pubmed_abstract><journal>Oncogene</journal><pubmed_title>The microRNA-3622 family at the 8p21 locus exerts oncogenic effects by regulating the p53-downstream gene network in prostate cancer progression.</pubmed_title><pmcid>PMC9177620</pmcid><funding_grant_id>W81XWH-21-1-0100</funding_grant_id><funding_grant_id>U54 CA118623</funding_grant_id><funding_grant_id>U54 CA118948</funding_grant_id><funding_grant_id>U54 CA118638</funding_grant_id><funding_grant_id>P30 CA013148</funding_grant_id><funding_grant_id>W81XWH-20-1-0426</funding_grant_id><funding_grant_id>CA118948</funding_grant_id><pubmed_authors>Hu F</pubmed_authors><pubmed_authors>Liu Z</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Bae S</pubmed_authors><pubmed_authors>Wei S</pubmed_authors><pubmed_authors>Liu R</pubmed_authors><pubmed_authors>Zhang C</pubmed_authors><pubmed_authors>Xu Z</pubmed_authors><pubmed_authors>Wen W</pubmed_authors><pubmed_authors>Li M</pubmed_authors><pubmed_authors>Zhou J</pubmed_authors><pubmed_authors>Wang L</pubmed_authors></additional><is_claimable>false</is_claimable><name>The microRNA-3622 family at the 8p21 locus exerts oncogenic effects by regulating the p53-downstream gene network in prostate cancer progression.</name><description>For human prostate cancer, the chromosome 8p21 locus, which contains NKX3.1 and the microRNA (miR)-3622 family (miR-3622a/b), is a frequently deleted region. Thus, miR-3622 is proposed as a suppressor for prostate cancer, but its role remains debatable. In the present study, we found that expression of miR-3622a was lower, whereas expression of miR-3622b-3p was higher in human prostate cancer tissues than in normal prostate tissues. miR-3622a-3p inhibited cell migration and invasion of human prostate cancer cells, whereas miR-3622b-3p facilitated cell proliferation, migration, and invasion. To address the opposing roles of miR-3622 family members in various human prostate cancer cell lines, we knocked out (KO) endogenous miR-3622, including both miR-3622a/b. Our results showed that miR-362</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jun</publication><modification>2025-04-19T22:46:31.713Z</modification><creation>2025-04-19T22:46:31.713Z</creation></dates><accession>S-EPMC9177620</accession><cross_references><pubmed>35501464</pubmed><doi>10.1038/s41388-022-02289-8</doi></cross_references></HashMap>